BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17192710)

  • 1. Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals.
    Pontali E
    Chemotherapy; 2007; 53(1):26-9. PubMed ID: 17192710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
    Dickinson L; Khoo S; Back D
    Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytochrome P450 in antiretroviral drug interactions.
    Walubo A
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):583-98. PubMed ID: 17696808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging antiretroviral drug interactions.
    Pham PA; Flexner C
    J Antimicrob Chemother; 2011 Feb; 66(2):235-9. PubMed ID: 21131695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drugs.
    Warnke D; Barreto J; Temesgen Z
    J Clin Pharmacol; 2007 Dec; 47(12):1570-9. PubMed ID: 18048575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001.
    Harris NS; Fowler MG; Sansom SL; Ruffo N; Lampe MA
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S33-41. PubMed ID: 17825649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of anti-infectives: a review.
    Barcia E; Negro S
    Chemotherapy; 2005 Jul; 51(4):197-9. PubMed ID: 16006766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug interactions of antimicrobial agents in children with cancer].
    Langebrake C; Uhlenbrock S; Ritter J; Groll AH
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S165-74. PubMed ID: 16288362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions with newer antiretroviral agents.
    Aberg JA
    Top HIV Med; 2008 Dec; 16(5):146-50. PubMed ID: 19106429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    S Afr Med J; 2008 Feb; 98(2):109-13. PubMed ID: 18350204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patterns of antiretroviral drug prescription in 997 Colombian patients].
    Machado JE; Alzate JA
    Biomedica; 2008 Mar; 28(1):78-86. PubMed ID: 18645663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries.
    Dooley KE; Flexner C; Andrade AS
    J Infect Dis; 2008 Oct; 198(7):948-61. PubMed ID: 18713054
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical management of drug interaction with antiretroviral agents.
    Pau AK
    Curr Opin HIV AIDS; 2008 May; 3(3):319-24. PubMed ID: 19372985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.